ConductScience.org, home

Paper36933835

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes.

Takamatsu Y and 6 others. Virus Res, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes. Papers, record 36933835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36933835

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes.
PubMed
Journal
Virus Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2023-05-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takamatsu YYuki
2Hayashi SSanae
3Kumamoto HHiroki
4Imoto SShuhei
5Tanaka YYasuhito
6Mitsuya HHiroaki
7Higashi-Kuwata NNobuyo

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B, ChronicMajor topic
Hepatitis BMajor topic
Humans
Mice
Animals
Hepatitis B virus
Hepatocytes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIABC011486NIH

Source NIH RePORTER

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127100145Discontinuation of oral antivirals in chronic hepatitis B: A systematic review.Hepatology2016https://conductscience.org/library/papers/27100145PubMed
233734564The struggle of a good friend getting old: cellular senescence in viral responses and therapy.EMBO Rep2021https://conductscience.org/library/papers/33734564PubMed
331319796HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models.BMC Cancer2019https://conductscience.org/library/papers/31319796PubMed
419656618Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.Cancer Lett2010https://conductscience.org/library/papers/19656618PubMed
517512084Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.J Hepatol2007https://conductscience.org/library/papers/17512084PubMed
635851277Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells.Nat Commun2022https://conductscience.org/library/papers/35851277PubMed
733999179Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.J Infect Dis2021https://conductscience.org/library/papers/33999179PubMed
811679961Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.Hepatology2001https://conductscience.org/library/papers/11679961PubMed
929608137Mechanisms and functions of cellular senescence.J Clin Invest2018https://conductscience.org/library/papers/29608137PubMed
1036152762Reverse inflammaging: Long-term effects of HCV cure on biological age.J Hepatol2023https://conductscience.org/library/papers/36152762PubMed
1115331414Near completely humanized liver in mice shows human-type metabolic responses to drugs.Am J Pathol2004https://conductscience.org/library/papers/15331414PubMed
1233333207Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV.J Hepatol2021https://conductscience.org/library/papers/33333207PubMed
1333715896Is there any need for new, long-acting nucleos(t)ide analogues for the treatment of hepatitis B infection?J Hepatol2021https://conductscience.org/library/papers/33715896PubMed
1435171034Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy.Microbiol Spectr2022https://conductscience.org/library/papers/35171034PubMed
1531675495Cellular Senescence: Defining a Path Forward.Cell2019https://conductscience.org/library/papers/31675495PubMed
1635576953Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.Lancet Gastroenterol Hepatol2022https://conductscience.org/library/papers/35576953PubMed
1735430754Precision medicine in the era of potent antiviral therapy for chronic hepatitis B.J Gastroenterol Hepatol2022https://conductscience.org/library/papers/35430754PubMed
1834818068Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.J Virol2022https://conductscience.org/library/papers/34818068PubMed
1934517409Virus-induced senescence is a driver and therapeutic target in COVID-19.Nature2021https://conductscience.org/library/papers/34517409PubMed
2029477613Hallmarks of Cellular Senescence.Trends Cell Biol2018https://conductscience.org/library/papers/29477613PubMed

See all 64 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41613597Current status and challenges of therapeutic targets, novel drugs and delivery systems for hepatitis B: how far to our goal?Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41613597PubMed
41521283Mitochondria-endoplasmic reticulum contact sites in hepatocytic senescence.Cell Mol Biol Lett2026https://conductscience.org/library/papers/41521283PubMed
39831159An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.PNAS Nexus2025https://conductscience.org/library/papers/39831159PubMed
38977798Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations.Sci Rep2024https://conductscience.org/library/papers/38977798PubMed
37753486Contribution of viral and bacterial infections to senescence and immunosenescence.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37753486PubMed

Download CSV of cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACSM36296PubTator's text mininghttps://conductscience.org/library/genes/6296NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CDKN1A1026PubTator's text mininghttps://conductscience.org/library/genes/1026NCBI Gene
CDKN1B1027PubTator's text mininghttps://conductscience.org/library/genes/1027NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720NCBI Gene
H2AC188337PubTator's text mininghttps://conductscience.org/library/genes/8337NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
LIPC3990PubTator's text mininghttps://conductscience.org/library/genes/3990NCBI Gene
LMNB14001PubTator's text mininghttps://conductscience.org/library/genes/4001NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PLAU5328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

See all 21 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36933835

GET https://conductscience.org/api/papers/v1/36933835/references?page=2